Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B
(NF-kB)-Dependent Pathway

Yu Cheng; Xiaofang Che; Simeng Zhang; Tianshu Guo; Xin He; Yunpeng Liu; Xiujuan Qu

doi:10.12659/MSM.925019

03 September 2020: Clinical Research

Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B (NF-κB)-Dependent Pathway

Yu Cheng ^123ABCDEG , Xiaofang Che ^123A , Simeng Zhang ^123C , Tianshu Guo ^123F , Xin He ^123F , Yunpeng Liu ^123AG* , Xiujuan Qu ^123AG*

DOI: 10.12659/MSM.925019

Med Sci Monit 2020; 26:e925019

Authors information Article notes Copyright and License information

View HTML version

Figure 5 CXCR4 and EGFR levels influence the prognosis of patients with gastric cancer. CXCR4 and EGFR levels influence the prognosis of patients with gastric cancer. Kaplan-Meier analysis of overall survival (OS) for EGFR (A) and CXCR4 (B) expressions in all gastric cancer patients (n=56, P=0.001 and P=0.011). (C) Kaplan-Meier analysis of OS for patients with co-expression of CXCR4 and EGFR was undertaken (P=0.002).

Back to the Article

Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B (NF-κB)-Dependent Pathway

Your Privacy